Sex steroids (SS) a r e known t o stimulate linear growth and increase somatomedin-C (Sm-C) levels in normal children. To determine if SS potentiate t h e Sm-C response t o growth hormone (GH) or if this increase is secondary t o SS enhanced GH secretion, we investigated t h e effects of short term SS therapy on imrnunoreactive Sm-C levels in GH deficient children. Six males were treated with oxandrolone (0.125 mglkgld) and 4 females with ethinyl estradiol (0.25 ug/kg/d) before and during GH therapy (0.1 IU/kg/d). Sm-C levels were determined before starting therapy (basal), three days a f t e r beginning SS, three days a f t e r combined GH + SS, and three days after GH alone. y m ' S t u a r t A. C h a l e w , S a l v a t o r e R a i t i , a n d A.
Using the paired t test, no difference was noted between the basal and SS treatment levels. In all patients, t h e GH alone and GH + SS concentrations were greater than t h e basal levels (p < .01). The mean Sm-C levels were significantly lower during GH + SS therapy than during therapy with GH alone (p <.05). These data suggest that short term SS therapy does not potentiate, and may inhibit, the Sm-C response t o GH. We conclude that the increase in Sm-C observed during puberty in response t o sex steroids in normal children may be mediated by enhanced GH release.
RESPONSE TO THERAPY IN CHILDREN WITH LOW
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y m ' S t u a r t A. C h a l e w , S a l v a t o r e R a i t i , a n d A.
Med=e,-tzent o f P e d i a t r i c s , B a l t i m o r e . We h a v e ~r e v i o u s l y d e m o n s t r a t e d t h a t t h e r e s p o n s e o f GH t o p h a r m a c o l o g i c s t i m u l a t i o n d o e s n o t a l w a y s c o r r e s p o n d to t h e a c t u a l i n t e g r a t e d c o n c e n t r a t i o n o f GH (ICGH) (JCEM 4 8 : 8 1 1 , 1 9 7 9 ) . S p i l i o t i s e t a 1 h a v e r e p o r t e d t h a t 3 o f 7 c h i l d r e n w h o h a d a n o r m a l r e s p o n s e t o GH p r o v o c a t i v e t e s t s b u t a r e d u c e d a m p l i t u d e or f r e q u e n c y o f GH p u l s e s , r e s p o n d e d to GH t h e r a p y ( A b s t r a c t 5 2 8 E n d o c r . S o c . 1 9 8 3 ) .
We m e a s u r e d ICGH i n 1 5 g r o w t h h o r m o n e d e f i c i e n t (GHD) c h i l d r e n a n d i n 9 4 c h i l d r e n w i t h g r o w t h i m p a i r m e n t w h o e x h i b i t e d a n o r m a l r e s p o n s e t o GH p K O v O C a t i~e t e s t s (GHNR).
T h e ICGH O f t h e 1 5 GHD c h i l d r e n r a n g e d f r o m 0.2 t o 2.6 n g / m l .
I n 7 5 o f t h e 9 4 GHNR c h i l d r e n , t h e ICGH w a s a b o v e 2.6 ng/ml.
T h e ICGH o f t h e 1 9 r e m a i n i n g GHNR c h i l d r e n w a s b e l o w 2.6 n g / m l .
T o d a t e , 6 o f t h e s e 1 9 c h i l d r e n h a v e b e e n t r e a t e d w i t h GH f o r m o r e t h a n 5 m o n t h s .
A l l 6 r e s p o n d e d t o GH t h e r a p y ( 2 more t h a n d o u b l e d t h e i r g r o w t h r a t e , t h e r e m a i n i n g 4 i n c r e a s e d t h e i r g r o w t h r a t e by more t h a n 2 c m / y r ) . 
C o n c l u s i o n : g r o w t h i m p a i r e d p a t i e n t s w i t h l o w ICGH s h o u l d b e t r e a t e d w i t h GH e v e n i f t h e y e x h i b i t a n o r m a l r e s p o n s e t o p r o v o c a t i v e t e s t s .
--
Brooklyn, N.Y. There a r e suggestions of an impairment in t e s t o s t e r o n e synt h e s i s and/or t e s t o s t e r o n e s e c r e t i o n in d i a b e t i c animals and humans. The k i n e t i c s of human chorionic gonadotropin-induced s t e r o i d o g e n i c response of t h e human t e s t i s was evaluated by adm i n i s t r a t i o n of hCG t o s i x normal adolescent c o n t r o l s (N) and s i x insulin-dependent adolescent d i a b e t i c males during a period of poor d i a b e t i c control (DPC) and repeated t h r e e months l a t e r a f t e r o b t a i n i n g good control (DM) by m u l t i p l e d a i l y i n s u l i n inj e c t i o n s .
HCG was administered in a s i n g l e i n j e c t i o n of 6,000 I l l ( P r e g n y l , Organon Lab) a t 9:OO a.m. and bloods were drawn a t 0,1,2,4,6,12,24 and 48 hr f o r plasma t e s t o s t e r o n e l e v e l s , d e t e rmined by R I A . Hg A~c was N 5.0?:~1.4, DPC 13.2%41.9, DGC 7.5%tl (p<0.01). Plasma t e s t o s t e r o n e l e v e l s mean t SE (ng/ml) in DPC was a t 0 452t115; 1 hr 448+110; 2 hr 591t151; 4 hr 569t120; 6 hr 581+127; 8 hr 502+124; 12 hr 620'153; 24 hr 932'239 and 48 hr 1345'364.
In DGC was a t 0 723'87; 1 hr 743'39; 2 hr 860'51; 4 hr 953'137; 6 hr 856'142; 8 hr 970'127; 12 hr 1116+200; 24 hr 1566'298 and 48 hr 1896t231. Plasma t e s t o s t e r o n e in DGC were not d i f f e r e n t from N. J u v e n i l e d i a b e t i c s in poor control had low basal and post hCG plasma t e s t o s t e r o n e l e v e l s than during a period of good d i a b e t i c c o n t r o l , This study suggests impaired androgen production in male adolescent d i a b e t i c s in poor cont r o l . Low t e s t o s t e r o n e production may be r e l a t e d t o sexual dysf u n c t i o n , growth r e t a r d a t i o n , and a t h e r o s c l e r o s i s in adolescent d i a b e t i c s . (Supported by N I H g r a n t RR-318). We have reported cardiopathy in j u v e n i l e d i a b e t i c s in poor control which improves with good glycemic control (Ped Res 16: 97A, 1982) . Glycosylation of heart myoglobin may play a r o l e in t h i s type of r e v e r s i b l e d i a b e t i c cardiopathy. Myoglobin i s simi l a r t o the B-chain of hemoglobin (Hgb) and has a s u f f i c i e n t number of l y s i n e residues and amino terminus t o be glycosylated l i k e Hgb. Twelve r a t s , 2m o l d , were injected with 60mg/kg s t r e ptozotocin by t h e penial vein and 12 control (C) r a t s were inj e c t e d w i t h s a l i n e . Glycosuria and hyperglycemia (blood sugar g r e a t e r than 400mg/dl) were present in the d i a b e t i c (D) r a t s . After 12 wks t h e r a t s were k i l l e d . Hearts were perfused through coronary a r t e r i e s w i t h 0.85% NaCl u n t i l c l e a r . D had heart wts of 1.11+0.07 gm vs C 0.98+0.18 om. Hearts were minced in a mort a r , leached with 10 times i t s volume 0.01N potassium phosphate b u f f e r , pH 7.0, w i t h 5mM EOTA and centrfigued a t 20,000 g f o r 10 min. The c l e a r supernatant containing myoglobin was f i l t e r e d through a 1.6 x 40cm column of Sephadex G-100 s u p e r f i n e gel and d i l u t e d in 2.lml f r a c t i o n s with t h e phosphate buffer. Protein was measured by Lowry and g l y c o s y l a t i o n by t h e modified TBA method of Ney e t a l (Anal. Biochem 118:294, 1981) . D r a t s had 8.26'2.50 (~' s E ) 0~4 4 3 per mg p r o t e i n and control 2.19'0.32, P<0.005. Markedly increased qlycosylation of heart myoglobin may change the oxyqen a f f i n i t y and subsequently t h e c o n t r a c t ib i l i t y of c a r d i a c muscle and c o n t r i b u t e t o t h e cardiopathy of j u v e n i l e d i a b e t i c s in poor c o n t r o l . S t u a r t A. C h a l e w , S a l v a t o r e R a i t i , a n d A. A v i n o a m --K o w a r s k 1 7 U n i v e r s i t~%~M a r y l a n d o~o f M e a~~ D e D a r t m e n t o f P e d i a t r i c s . B a l t i m o r e . l let hen a n d C h a s l o w (JCEM 5 7 : 1 0 3 1 , 1 9 8 3 ) , r e c e n t l y r e p o r t
GLYCOSYLATION OF HEART MYOGLOBIN I N DIABETIC RATS
e d t h a t t h e r a t i o o f GH b y T a n d e m H y b r i t e c h m o n o c l o n a l i m m u n o r a d i o m e t r i c a s s a y ( T a n d e m ) t o s t a n d a r d p o l y c l o n a l r a d i o i m m u n o a s s a y ( R I A ) , m i g h t p r e d i c t t h e o u t c o m e o f GH t h e r a p e u t i c t r i a l s . We s t u d i e d t h e e f f e c t o f GH t h e r a p y o n 1 6 p a t i e n t s w h o s e h e i g h t w a s ( 3 r d p e r c e n t i l e a n d b o n e a g e d e l a y e d > 2 SD.
E a c h p a t i e n t h a d a n o r m a l GH r e s p o n s e ( > l o -n g / m l ) t o i n s u l i n a r g i n i n e s t i m u l a t i o n ( a s s a y e d -b y RIA). GH was a l s o a s s a y e d by Tandem. S e v e n p a t i e n t s i n c r e a s e d t h e i r p r e t r e a t m e n t g r o w t h r a t e b y > 2 cm/yr ( R ) .
N i n e p a t i e n t s d i d n o t r e s p o n d t o GH ( N R ) .
R e s u l t s : T h e r e w a s n o s i c l n i f i c a n t d i f f e r e n c e b e t w e e n t h e Tandem/RIA r a t i o o f -R a n d NR p a t i e n t s .
On-GH
T h e r a t i o d i d n o t p r e d i c t t h e r e s p o n s e to GH . t h e r a p y .
ANDROSTENE SULFATES IN AMNIOTIC FLUID AND CORD BLOOD: A POSSIBLE APPROACH TO PRENATAL DIAGNOSIS OF SMITH-
419 LmLI-OPITZ SYNDROME (SLO). Fred Chasalow, Sandra
Blethen and Kutay Taysi, Washington U n i v e r s i t y , S t . Louis C h i l d r e n ' s Hospital, Department of P e d i a t r i c s , S t . Louis, MO.
We have previously shown t h a t during t h e f i r s t month of l i f e t h e r e a r e 4 androstene s u l f a t e s present i n serum. Two of t h e s e have been i d e n t i f i e d a s t h e s u l f a t e s of dehydroepiandrosterone (DHEA) and 16a-hydroxy-DHEA; t h e o t h e r s ( I 1 and IV) a r e u n i d e n t i f i e d . Of t h e four, DHEA-sulfate i s present i n t h e s m a l l e s t amounts. We have extended our s t u d i e s t o cord blood and second t r i m e s t e r amniotic f l u i d . S t e r o i d s u l f a t e s were e x t r a c t e d w i t h ethanol-ethyl a c e t a t e (1:2) and hydrolyzed with Helix pomatia e x t r a c t ; t h e 5-androstenes were sparated by f l a s h chromatography and d e t e c t e d in a radioimmunoassay i n which DHEA and 16a-hydroxy-DHEA c r o s s r e a c t but pregnenolone and 17-hydroxypregnenolone do n o t . DHEA, 16a-hydroxy DHEA and I 1 (an a c i dl a b i l e m a t e r i a l ) were found i n both cord blood nd amniotic 1 f l u i d ; I V was n o t present i n e i t h e r . When (7a-HIDHE.4-sulfate was added t o cord blood o r amniotic f l u i d , no r a d i o l a b l e was found i n I 1 o r 16-a-hydroxy-DHEA.
Thus, n e i t h e r i s an a r t i f a c t of i s o l a t i o n . Compound I 1 may r e p r e s e n t t h e product of an h i t h e r t o u n i d e n t i f i e d pathway. I n t h e f i r s t week of l i f e , c h i l d r e n with SLO do not have I 1 i n t h e i r serum. The f a c t t h a t
